Skip to content

Role of Ropivacaine in the management of post-operative pain.

Evaluation of optimal dose of epidural background infusion of Ropivacaine in the management of post-operative pain.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025565
Enrollment
80
Registered
2020-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere

Interventions

Intervention1: GROUP WITH 50% OF EPIDURAL DOSE AS BACKGROUND INFUSION: 50% of the hourly epidural dose will be in the form of background infusion( remaining 50% as demand dose) Control Intervention1:

Sponsors

Dr Anil Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients of either sex, ASA physical status I or II, who are scheduled for abdominal surgery under general anaesthesia and thoracic epidural analgesia, will be included in the study.

Exclusion criteria

Exclusion criteria: Patient refusal and patients who are unable to understand the numerical rating scale for pain assessment, will be excluded in the study.

Design outcomes

Primary

MeasureTime frame
Post-operative NRS score for dynamic pain(coughing)Timepoint: At 0(zero) hours, 6 hours, 12 hours, 18 hours, 24 hours, 30 hours, 36 hours, 42 hours, 48 hours, 54 hours,60 hours, 66 hours, 72 hours.

Secondary

MeasureTime frame
Post-operative nausea and vomiting (PONV), reqirement of rescue analgesia and rescue anti-emetic, hypotension, motor block, sedation, pruritis and respiratory depression.Timepoint: At 0(zero) hours, 6 hours, 12 hours, 18 hours, 24 hours, 30 hours, 36 hours, 42 hours, 48 hours, 54 hours, 60 hours, 66 hours, 72 hours.

Countries

India

Contacts

Public ContactDr Jyotsana Jaiswal

Sanjay Gandhi Postgraduate Institute of Medical Sciences

anil_sgpgi@hotmail.com8004904589

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026